SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001787306-23-000076
Filing Date
2023-08-08
Accepted
2023-08-08 16:04:26
Documents
14
Period of Report
2023-08-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K arqt-20230808.htm   iXBRL 8-K 27947
2 EX-99.1 pressreleaseex991q22023.htm EX-99.1 104319
6 a1a82.jpg GRAPHIC 25530
  Complete submission text file 0001787306-23-000076.txt   311309

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT arqt-20230808.xsd EX-101.SCH 1889
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT arqt-20230808_lab.xml EX-101.LAB 26155
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT arqt-20230808_pre.xml EX-101.PRE 13573
8 EXTRACTED XBRL INSTANCE DOCUMENT arqt-20230808_htm.xml XML 2864
Mailing Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361
Business Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361 805-418-5006
Arcutis Biotherapeutics, Inc. (Filer) CIK: 0001787306 (see all company filings)

IRS No.: 812974255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39186 | Film No.: 231151138
SIC: 2834 Pharmaceutical Preparations